Financials
- Market Capitalization 222.39 M
- Employee 130
- Founded 2016
- CEO N/A
- Website www.nautilus.bio
- Headquarter Washington, United States
- FIGI BBG00W7G4M12
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.15
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3555 | AVXL Anavex Life Sciences Corp. - Common Stock | 2.43 USD | +3.40% | -8.65% | -2.41% | -77.79% | 225.19 M USD | ||
| 3561 | CHRS Coherus Oncology, Inc. - Common Stock | 1.45 USD | -1.36% | -11.04% | +5.84% | -9.94% | 223.66 M USD | ||
| 3567 | DTIL Precision BioSciences, Inc. - Common Stock | 8.58 USD | -0.12% | -7.84% | +38.16% | +97.24% | 221.38 M USD | ||
| 3569 | OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 3.69 USD | -3.40% | -5.87% | -7.75% | +25.51% | 220.96 M USD |